News
The recall affects 4 oz. bottles of the natural cough syrup distributed across the United States between December 2022 and ...
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It’s the first step in an anticipated global rollout that could protect ...
On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an ...
Gilead’s Yeztugo will offer an alternative to treatments such as daily pills and every-other-month injections.
A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...
The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV, a move the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results